FIELD: pharmaceutical industry.
SUBSTANCE: invention provides antituberculous formulation made in the form of solid dosage form containing as active principle combination of isoniazid, rifampicin, pyrazinamide, ethambutol hydrochloride, and pyridoxine hydrochloride plus pharmaceutically acceptable auxiliaries: starch, lubricant, and optionally microcrystalline cellulose. Composition is characterized by storage stability and high therapeutical efficiency.
EFFECT: increased assortment of antituberculous drugs.
6 cl, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED ANTI-TUBERCULOSIS PREPARATION | 2007 |
|
RU2354378C1 |
COMPOSITE FORMULATION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247560C1 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
ANTITUBERCULOUS AGENT | 2003 |
|
RU2247559C1 |
COMBINED ANTITUBERCULOUS DRUG AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2431487C2 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2422145C2 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
COMBINED ANTITUBERCULAR PREPARATION AND METHOD FOR ITS OBTAINING | 2001 |
|
RU2182483C1 |
Authors
Dates
2005-03-10—Published
2003-12-29—Filed